𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy and safety of leukocite-derived ?-interferon (leu ?-IFN) in the treatment of chronic hepatitis C: A prospective controlled study . Institute of Medical Therapy, 2nd University of Naples, Faculty of Medicine

✍ Scribed by Palazzo, Juan P.; Lloyd, Joshua M.

Book ID: 122426343
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 150 KB
Volume: 22
Category: Article
ISSN: 0270-9139
DOI: 10.1016/0270-9139(95)94184-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of interferon therapy on the risk

Effect of interferon therapy on the risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis C: a large retrospective cohort study of 3296 patients: Yasuharu Imai, Ikeda Municipal Hospital, Ikeda Japan; Akinori Kasahara, Osaka University Hospital, Suita Japan; Takeshi Okanoue, Kyoto Prefectural University of Medicine, Kyoto Japan; Hirohito Tsubouchi, Miyazaki Medical College, Miyazaki Japan; Sumio Kawata, Yamagata University School of Medicine, Yamagata Japan; Shinji Tamura, Osaka University Graduate School of Medicine, Suita Japan; Kentaro Yoshioka, Nagoya University School of Medicine, Nagoya Japan; Kendo Kiyosawa, Shinshu University School of Medicine, Matsumoto Japan; Shinichi Kakumu, Aichi Univ Sch of Medicine, Aichi Japan; Kiwamu Okita, Yamaguchi University School of Medicine, Ube Japan; Norio Hayashi, Osaka University Graduate School of Medicine, Suita Japan

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Efficacy of daily interferon-alpha-2B (I

Efficacy of daily interferon-alpha-2B (IFN-α) in combination with ribavirin in the treatment of naive patients with chronic hepatitis C (CHC): a randomised controlled trial: Nicolaos C Tassopoulos Mr, Western Attica Gen Hosp, Athens Greece; Ketikoglou Ioannis Mr, Hippokration Gen Hosp, Athens Greece; Dimitris Tsantoulas Mr, Sismanoglion Gen Hosp, Athens Greece; Maria Raptopoulou Mrs, Aristotelion Univ of Thessaloniki, Thessaloniki Greece; Emmanouil Paraskevas Mr, Agios Savvas Hosp, Athens Greece; Grigoris Hatzis Mr, Irini Vafiadis Mrs, Laikon Gen Hosp, Athens Greece; Dimitris Chrysagis Mr, Loimodon Hosp, Thessaloniki Greece; Stelios Kanatakis Mr, Red Cross Hosp, Athens Greece; Evangelos Akriviadis Mr, Hippokration Gen Hosp, Thessaloniki Greece; Vana Sypsa Mrs, Angelos Hatzakis Mr, Athens Univ Medical Sch, Athens Greece

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB